SVRA Savara, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 11, 2026
$4.81
· of 52w range
· above low
· to high
$3.3452w low
$7.0152w high
Market Cap (MRQ)
$988M
P/E
-9.1
EPS
$-0.53
your badges
52W Range
$3–$7
Analyst Rating
BUY
Price Target
$11
P/E
-9.1
ROE
-73.4%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
SVRA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.81
Market Cap (MRQ)
$988M
P/E
-9.1
EPS
$-0.53
ROE
-73.4%
Debt/Equity (MRQ)
0.2
52W Range
$3–$7
SVRA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2016-12-31 → 2020-12-31
EPS$-0.532021-12-31 → 2025-12-31
Free Cash Flow$-101M2016-12-31 → 2025-12-31
Net margin·2016-12-31 → 2020-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | SVRA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -9.15Y avg ≈-8.4 | ≈-8.4 | · | · | |
| P/B (MRQ) | 6.95Y avg ≈3.3 | ≈3.3 | 4.9 | Overvalued | |
| EV / EBITDA | -6.35Y avg ≈-4.7 | ≈-4.7 | · | · | |
| Price / FCF (TTM) | -8.95Y avg ≈-8.4 | ≈-8.4 | · | · | |
| Price / Cash Flow (TTM) | -9.05Y avg ≈-8.4 | ≈-8.4 | · | · | |
| EV / FCF (TTM) | -7.65Y avg ≈-5.6 | ≈-5.6 | · | · | |
| Price / Tangible Book | 4.95Y avg ≈3.3 | ≈3.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | SVRA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -51.0%5Y avg ≈-35.2% | ≈-35.2% | -21.8% | Weak | |
| ROE | -73.4%5Y avg ≈-43.6% | ≈-43.6% | -15.4% | Weak | |
| ROIC | -53.0% | · | -117.8% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | SVRA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.25Y avg ≈0.2 | ≈0.2 | · | · | |
| Current Ratio (MRQ) | 10.15Y avg ≈15.2 | ≈15.2 | 10.6 | Low liquidity | |
| Quick Ratio | 11.65Y avg ≈14.8 | ≈14.8 | 2.5 | Strong liquidity | |
| Long-Term Debt / Equity (MRQ) | 0.25Y avg ≈0.2 | ≈0.2 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-5.9%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 11, 2026 | $-0.16 | $-0.15 | -10.2% |
| March 31, 2026 | May 11, 2026 | $-0.15 | $-0.14 | -9.2% |
| Dec. 31, 2025 | $-0.13 | $-0.12 | -8.2% | |
| Sept. 30, 2025 | $-0.14 | $-0.14 | -3.5% | |
| June 30, 2025 | $-0.14 | $-0.12 | -12.6% | |
| March 31, 2025 | $-0.12 | $-0.13 | 8.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $257.0K | $0 | · | $0 | $400.0K | $54.0K | $0 | |
| SG&A Expense | $42M | $25M | $16M | $11M | $12M | $14M | $13M | $11M | $11M | $3M | $2M | $9M | |
| Operating Expenses | $124M | $103M | $60M | $39M | $41M | $50M | $79M | $70M | $30M | $11M | $6M | $29M | |
| Operating Income | $-124M | $-103M | $-60M | $-39M | $-41M | $-49M | $-79M | $-70M | $-30M | $-11M | $-6M | $-29M | |
| Interest Expense | · | · | · | · | · | · | · | · | $1M | $452.0K | $3M | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | $122.0K | $130.0K | $69.0K | |
| Other Non-op | $5M | $7M | $5M | $689.0K | $-2M | $-315.0K | $852.0K | $1M | $-3M | $-332.0K | $-3M | $508.0K | |
| Pretax Income | $-119M | $-96M | $-55M | $-38M | $-43M | $-50M | $-78M | $-69M | $-33M | $-11M | $-9M | $-29M | |
| Income Tax | $0 | $9.0K | · | · | · | · | · | $-7M | $-4M | $-357.0K | $0 | $0 | |
| Net Income | $-119M | $-96M | $-55M | $-38M | $-43M | $-50M | $-78M | $-62M | $-30M | $-11M | $-9M | $-29M | |
| EPS (Basic) | $-0.53 | $-0.48 | $-0.33 | $-0.25 | $-0.32 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.53 | $-0.48 | $-0.33 | $-0.25 | $-0.32 | · | · | · | · | · | · | · | |
| Shares (Basic) | 222,387,531 | 198,191,936 | 165,204,652 | 152,771,817 | 133,919,145 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 222,387,531 | 198,191,936 | 165,204,652 | 152,771,817 | 133,919,145 | · | · | · | · | · | · | · | |
| EBITDA | $-124M | · | $-60M | $-39M | $-41M | $-49M | $-78M | $-70M | $-30M | $-36M | $-39M | $-29M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $33M | $15M | $27M | $52M | $34M | $23M | $50M | $24M | $22M | $13M | $17M | $13M | |
| Short-term Investments | $203M | $181M | $136M | $74M | $127M | $59M | $72M | $87M | $72M | $0 | · | · | |
| Prepaid Expense | $6M | $6M | $4M | $3M | $4M | $3M | $2M | $3M | $4M | $840.0K | $1M | $1M | |
| Current Assets | $242M | $202M | $166M | $129M | $165M | $85M | $124M | $113M | $98M | $15M | $42M | $58M | |
| PP&E (Net) | $100.0K | $165.0K | $270.0K | $51.0K | $73.0K | $156.0K | $352.0K | $522.0K | $925.0K | $793.0K | $226.0K | $188.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $565.0K | $532.0K | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $851.0K | $504.0K | $339.0K | $344.0K | |
| Goodwill | · | · | · | · | · | $0 | · | $27M | $27M | $3M | $3M | $3M | |
| Other Non-current Assets | $84.0K | $242.0K | $387.0K | $116.0K | $251.0K | $250.0K | $673.0K | $131.0K | $131.0K | $131.0K | $183.0K | $353.0K | |
| Total Assets | $253M | $213M | $178M | $140M | $177M | $98M | $136M | $152M | $160M | $29M | $54M | $70M | |
| Accounts Payable | $6M | $5M | $4M | $1M | $1M | $3M | $3M | $4M | $3M | $536.0K | $3M | $1M | |
| Accrued Liabilities | $15M | $10M | $7M | $5M | $5M | $6M | $5M | $3M | $3M | $2M | $8M | $6M | |
| Current Liabilities | $20M | $15M | $11M | $6M | $15M | $8M | $11M | $7M | $6M | $3M | $23M | $8M | |
| Capital Leases | · | $100.0K | $200.0K | $50.0K | $100.0K | $100.0K | $300.0K | · | $297.0K | $579.0K | $25.0K | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $7M | $2M | $3M | $3M | |
| Other Non-current Liabilities | $0 | $87.0K | $247.0K | $54.0K | $117.0K | $84.0K | $513.0K | $70.0K | · | · | · | · | |
| Total Liabilities | $50M | $41M | $37M | $32M | $32M | $33M | $35M | $44M | $40M | $21M | $30M | $12M | |
| Long-term Debt | $30M | $27M | $26M | $26M | $26M | $25M | · | · | · | · | · | · | |
| Total Debt | $30M | · | $26M | $26M | $26M | · | · | · | · | · | · | · | |
| Common Stock | $204.0K | $173.0K | $140.0K | $116.0K | $116.0K | $55.0K | $52.0K | $36.0K | $32.0K | $5.0K | $164.0K | $159.0K | |
| Retained Earnings | $-608M | $-489M | $-393M | $-339M | $-301M | $-258M | $-208M | $-130M | $-68M | $-38M | $-275M | $-235M | |
| AOCI | $-87.0K | $-750.0K | $-271.0K | $-605.0K | $5.0K | $942.0K | $-17.0K | $200.0K | $958.0K | $-591.0K | $-17.0K | $-25.0K | |
| Stockholders' Equity | $203M | $171M | $140M | $108M | $144M | $64M | $102M | $108M | $119M | $-36M | $-27M | $-18M | |
| Liabilities + Equity | $253M | $213M | $178M | $140M | $177M | $98M | $136M | $152M | $160M | $29M | $54M | $70M | |
| Shares Outstanding | 204,567,283 | 172,423,223 | 138,143,545 | 114,046,345 | 114,036,892 | 54,152,955 | 50,790,441 | 35,146,096 | 30,509,522 | 3,162,573 | 163,614,297 | 159,458,376 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $87.0K | $130.0K | $77.0K | $31.0K | $136.0K | $255.0K | $1M | $526.0K | · | $99.0K | $146.0K | $85.0K | |
| Stock-based Comp | $14M | $10M | $4M | $2M | $3M | $5M | $4M | $4M | $552.0K | $209.0K | $153.0K | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | $-7M | $-3M | $-2M | · | · | |
| Other Non-cash | · | · | · | · | · | · | $28M | · | · | · | · | · | |
| Operating Cash Flow | $-101M | $-89M | $-51M | $-35M | $-40M | $-40M | $-45M | $-39M | $-28M | $-8M | $-5M | $-25M | |
| CapEx | $22.0K | $25.0K | $296.0K | $9.0K | $57.0K | $47.0K | $148.0K | $141.0K | $495.0K | $8.0K | $165.0K | $147.0K | |
| Investing Cash Flow | $-18M | $-40M | $-57M | $53M | $-69M | $9M | $16M | $-14M | $-69M | · | · | · | |
| Debt Issued | $30M | · | · | $26M | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $2M | · | · | $88.0K | · | · | · | · | $-4M | · | · | · | |
| Stock Issued | · | · | · | · | · | $2M | $30M | $505.0K | $2M | $20M | $2M | $30M | |
| Net Stock Activity | · | · | · | · | · | $2M | $30M | $505.0K | $2M | $20M | $2M | $30M | |
| Financing Cash Flow | $138M | $118M | $83M | $87.0K | $121M | $4M | $55M | $55M | $106M | · | · | · | |
| Net Change in Cash | $18M | $-11M | $-26M | $18M | $11M | $-27M | $26M | $2M | $9M | $-3M | $4M | $10M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-101M | · | $-51M | $-35M | $-40M | $-40M | $-45M | $-39M | $-29M | $-37M | $-33M | $-25M | |
| Levered FCF | · | · | · | · | · | · | · | · | $-30M | $-39M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -19182.9% | · | · | · | -28481.2% | · | · | |
| Net Margin | · | · | · | · | · | -19305.5% | · | · | · | -28203.1% | · | · | |
| Pretax Margin | · | · | · | · | · | -19305.5% | · | · | · | -30085.2% | · | · | |
| EBITDA Margin | · | · | · | · | · | -19182.9% | · | · | · | -28481.2% | · | · | |
| ROA | -51.0% | · | -34.5% | -24.1% | -31.4% | -42.4% | -54.2% | -39.4% | -31.6% | -100.1% | -63.9% | -45.6% | |
| ROE | -73.4% | · | -38.1% | -34.0% | -28.7% | -70.4% | -75.0% | -54.4% | -71.4% | 410.9% | -1425.5% | -53.9% | |
| ROIC | -53.0% | · | · | · | · | · | · | -56.9% | -22.4% | -350.2% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.8 | · | 15.7 | 22.0 | 11.3 | 10.4 | 11.4 | 15.6 | 16.3 | 2.5 | 1.8 | 6.9 | |
| Quick Ratio | 11.6 | · | 15.3 | 21.5 | 11.0 | 10.1 | 11.2 | 15.3 | 15.7 | 1.8 | 1.0 | 4.2 | |
| Debt / Equity | 0.1 | · | 0.2 | 0.2 | 0.2 | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.1 | · | 0.2 | 0.2 | 0.1 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -25.8 | -17.1 | -65.3 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.99 | · | $1.02 | $0.94 | $1.27 | $1.19 | $2.00 | $3.08 | $3.91 | $0.04 | $0.15 | $0.37 | |
| Cash Flow / Share | $-0.45 | · | $-0.31 | $-0.23 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.16 | · | $0.19 | $0.46 | $0.30 | $0.42 | $0.98 | $0.69 | $0.73 | $0.03 | $0.14 | $0.22 | |
| EPS (TTM) | $-0.53 | $-0.48 | $-0.33 | $-0.25 | $-0.32 | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | $257.0K | $0 | · | $0 | $400.0K | $54.0K | $0 | |
| Net Income TTM | $-119M | $-96M | $-55M | $-38M | $-43M | $-50M | $-78M | $-62M | $-30M | $-11M | $-9M | $-29M | |
| Market Cap | $1.23B | · | $649M | $177M | $141M | $62M | $228M | $266M | $453M | · | · | · | |
| Enterprise Value | $1.03B | · | $513M | $77M | $6M | · | · | · | · | · | · | · | |
| P/E | -11.4 | -6.4 | -14.2 | -6.2 | -3.9 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | 242.3 | · | · | · | · | · | · | |
| P/B | 6.1 | · | 4.6 | 1.6 | 1.0 | 1.0 | 2.2 | 2.5 | 3.8 | · | · | · | |
| P / Tangible Book | 6.1 | 3.1 | 4.6 | 1.6 | 1.0 | 1.0 | · | · | · | · | · | · | |
| P / Cash Flow | -12.2 | · | -12.7 | -5.1 | -3.5 | -1.6 | -5.0 | -6.8 | -16.0 | · | · | · | |
| P / FCF | -12.2 | · | -12.6 | -5.1 | -3.5 | -1.6 | -5.0 | -6.7 | -15.8 | · | · | · | |
| EV / EBITDA | -8.3 | · | -8.6 | -2.0 | -0.1 | · | · | · | · | · | · | · | |
| EV / FCF | -10.2 | · | -10.0 | -2.2 | -0.1 | · | · | · | · | · | · | · | |
| Earnings Yield | -8.8% | -15.6% | -7.0% | -16.1% | -25.8% | · | · | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $19M | $16M | $13M | $10M | $11M | $9M | $8M | $6M | $6M | $6M | $5M | $4M | $3M | $3M | $3M | $2M | |
| Operating Expenses | $41M | $39M | $33M | $30M | $31M | $28M | $31M | $26M | $23M | $22M | $18M | $18M | $12M | $12M | $11M | $11M | |
| Operating Income | $-41M | $-39M | $-33M | $-30M | $-31M | $-28M | $-31M | $-26M | $-23M | $-22M | $-18M | $-18M | $-12M | $-12M | $-11M | $-11M | |
| Other Non-op | $737.0K | $2M | $1M | $694.0K | $1M | $2M | $2M | $2M | $947.0K | $2M | $2M | $1M | $778.0K | $2M | $575.0K | $149.0K | |
| Pretax Income | · | · | · | · | · | $-27M | · | · | · | $-20M | · | · | · | · | · | · | |
| Net Income | $-40M | $-37M | $-32M | $-30M | $-30M | $-27M | $-29M | $-24M | $-22M | $-20M | $-16M | $-17M | $-11M | $-11M | $-10M | $-10M | |
| EPS (Basic) | $-0.16 | $-0.15 | $-0.13 | $-0.14 | $-0.14 | $-0.12 | $-0.14 | $-0.11 | $-0.12 | $-0.11 | $-0.09 | $-0.10 | $-0.07 | $-0.07 | $-0.07 | $-0.07 | |
| EPS (Diluted) | $-0.16 | $-0.15 | $-0.13 | $-0.14 | $-0.14 | $-0.12 | $-0.14 | $-0.11 | $-0.12 | $-0.11 | $-0.09 | $-0.10 | $-0.07 | $-0.07 | $-0.07 | $-0.07 | |
| Shares (Basic) | 253,569,891 | 253,280,551 | · | 216,462,161 | 216,431,348 | 216,146,934 | · | 211,847,651 | 182,584,078 | 182,550,109 | · | 174,696,191 | 152,796,617 | 152,781,580 | · | 152,773,015 | |
| Shares (Diluted) | 253,569,891 | 253,280,551 | · | 216,462,161 | 216,431,348 | 216,146,934 | · | 211,847,651 | 182,584,078 | 182,550,109 | · | 174,696,191 | 152,796,617 | 152,781,580 | · | 152,773,015 | |
| EBITDA | $-41M | $-39M | · | $-30M | $-31M | $-28M | · | $-26M | $-23M | $-22M | · | $-18M | $-12M | $-12M | · | $-11M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $42M | $39M | $33M | $16M | $17M | $20M | $15M | $21M | $24M | $17M | $27M | $28M | $23M | $34M | $52M | $120M | |
| Short-term Investments | $131M | $164M | $203M | $108M | $129M | $153M | $181M | $198M | $98M | $126M | $136M | $141M | $82M | $81M | $74M | $14M | |
| Prepaid Expense | $5M | $6M | $6M | $4M | $5M | $5M | $6M | $7M | $6M | $3M | $4M | $2M | $3M | $3M | $3M | $3M | |
| Current Assets | $178M | $209M | $242M | $128M | $151M | $177M | $202M | $226M | $128M | $146M | $166M | $170M | $108M | $118M | $129M | $137M | |
| PP&E (Net) | $641.0K | $130.0K | $100.0K | $85.0K | $119.0K | $138.0K | $165.0K | $206.0K | $236.0K | $248.0K | $270.0K | $277.0K | $264.0K | $47.0K | $51.0K | $59.0K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Other Non-current Assets | $2M | $886.0K | $84.0K | $990.0K | $1M | $1M | $242.0K | $1M | $1M | $1M | $387.0K | $1M | $888.0K | $868.0K | $116.0K | $876.0K | |
| Total Assets | $192M | $222M | $253M | $141M | $164M | $189M | $213M | $239M | $140M | $158M | $178M | $182M | $120M | $129M | $140M | $148M | |
| Accounts Payable | $7M | $4M | $6M | $4M | $5M | $6M | $5M | $5M | $3M | $3M | $4M | $3M | $3M | $2M | $1M | $893.0K | |
| Accrued Liabilities | $11M | $11M | $15M | $13M | $9M | $6M | $10M | $8M | $8M | $7M | $7M | $6M | $3M | $3M | $5M | $4M | |
| Current Liabilities | $18M | $16M | $20M | $17M | $14M | $12M | $15M | $13M | $11M | $10M | $11M | $9M | $6M | $5M | $6M | $5M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | $300.0K | · | · | · | · | |
| Other Non-current Liabilities | $770.0K | · | $0 | $0 | $0 | $44.0K | $87.0K | $128.0K | $169.0K | $208.0K | $247.0K | $284.0K | $20.0K | $37.0K | $54.0K | $71.0K | |
| Total Liabilities | $48M | $46M | $50M | $47M | $43M | $41M | $41M | $39M | $38M | $36M | $37M | $36M | $32M | $31M | $32M | $31M | |
| Long-term Debt | $30M | $30M | $30M | $30M | $30M | $30M | · | $27M | $26M | $26M | · | $26M | $26M | $26M | · | $26M | |
| Total Debt | $30M | $30M | · | $30M | $30M | $30M | · | $27M | $26M | $26M | · | $26M | $26M | $26M | · | $26M | |
| Common Stock | $204.0K | $204.0K | $204.0K | $173.0K | $173.0K | $173.0K | $173.0K | $172.0K | $140.0K | $140.0K | $140.0K | $137.0K | $116.0K | $116.0K | $116.0K | $116.0K | |
| Retained Earnings | $-686M | $-645M | $-608M | $-576M | $-546M | $-516M | $-489M | $-460M | $-436M | $-414M | $-393M | $-377M | $-361M | $-349M | $-339M | $-328M | |
| AOCI | $-534.0K | $-429.0K | $-87.0K | $-155.0K | $-216.0K | $-632.0K | $-750.0K | $299.0K | $-880.0K | $-742.0K | $-271.0K | $-942.0K | $-619.0K | $-461.0K | $-605.0K | $-2M | |
| Stockholders' Equity | $144M | $176M | $203M | $94M | $120M | $148M | $171M | $199M | $102M | $122M | $140M | $147M | $88M | $98M | $108M | $117M | |
| Liabilities + Equity | $192M | $222M | $253M | $141M | $164M | $189M | $213M | $239M | $140M | $158M | $178M | $182M | $120M | $129M | $140M | $148M | |
| Shares Outstanding | 205,399,365 | 204,922,140 | 204,567,283 | 172,850,443 | 172,836,922 | 172,703,390 | 172,423,223 | 170,842,763 | 138,199,047 | 138,176,641 | 138,143,545 | 135,339,836 | 114,150,455 | 114,064,736 | 114,046,345 | 114,042,642 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $28.0K | $24.0K | $-13.0K | $35.0K | $34.0K | $30.0K | $32.0K | $33.0K | $33.0K | $32.0K | $31.0K | $30.0K | $8.0K | $8.0K | $7.0K | $8.0K | |
| Stock-based Comp | $8M | $11M | $5M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $995.0K | $958.0K | $864.0K | $561.0K | $450.0K | |
| Operating Cash Flow | $-30M | $-33M | $-25M | $-23M | $-26M | $-27M | $-23M | $-23M | $-22M | $-21M | $-16M | $-13M | $-10M | $-12M | $-9M | $-8M | |
| CapEx | $222.0K | $54.0K | $2.0K | $2.0K | $15.0K | $3.0K | $-9.0K | $3.0K | $21.0K | $10.0K | $24.0K | $43.0K | $225.0K | $4.0K | $0 | $4.0K | |
| Investing Cash Flow | $33M | $39M | $-94M | $21M | $24M | $29M | $18M | $-98M | $30M | $11M | $7M | $-57M | $-1M | $-6M | $-59M | $33M | |
| Debt Issued | · | · | $0 | $0 | $0 | $30M | · | · | · | · | · | · | · | · | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $189.0K | $-195.0K | $136M | $-23.0K | $-49.0K | $2M | $-843.0K | $118M | $55.0K | $49.0K | $8M | $75M | $104.0K | $26.0K | $1.0K | $-1.0K | |
| Net Change in Cash | $3M | $6M | $17M | $-1M | $-2M | $4M | $-6M | $-2M | $7M | $-10M | $-1M | $5M | $-11M | $-18M | $-68M | $25M | |
| Free Cash Flow | · | $-33M | · | · | · | $-27M | · | · | · | $-21M | · | · | · | $-12M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -22.6% | -18.1% | · | -15.6% | -20.0% | -15.3% | · | -11.5% | -17.1% | -14.1% | · | -10.1% | -8.3% | -7.1% | · | -6.2% | |
| ROE | -30.5% | -23.0% | · | -20.1% | -27.4% | -19.8% | · | -14.0% | -23.5% | -18.5% | · | -12.6% | -10.7% | -9.0% | · | -7.6% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.1 | 13.5 | · | 7.7 | 11.1 | 14.9 | · | 17.7 | 11.3 | 14.9 | · | 19.0 | 18.3 | 23.9 | · | 26.5 | |
| Quick Ratio | 9.8 | 13.0 | · | 7.4 | 10.7 | 14.5 | · | 17.2 | 10.8 | 14.6 | · | 18.8 | 17.9 | 23.3 | · | 26.0 | |
| Debt / Equity | 0.2 | 0.2 | · | 0.3 | 0.2 | 0.2 | · | 0.1 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.3 | · | 0.2 | |
| LT Debt / Equity | 0.2 | 0.2 | · | 0.3 | 0.2 | 0.2 | · | 0.1 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.3 | · | 0.2 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.70 | $0.86 | · | $0.55 | $0.70 | $0.86 | · | $1.17 | $0.74 | $0.88 | · | $1.08 | $0.77 | $0.86 | · | $1.02 | |
| Cash Flow / Share | · | $-0.13 | · | · | · | $-0.13 | · | · | · | $-0.11 | · | · | · | $-0.08 | · | · | |
| Cash / Share | $0.20 | $0.19 | · | $0.09 | $0.10 | $0.11 | · | $0.13 | $0.17 | $0.12 | · | $0.20 | $0.20 | $0.30 | · | $1.05 | |
| EPS (TTM) | $-0.58 | $-0.56 | · | $-0.54 | $-0.51 | $-0.49 | · | $-0.43 | $-0.42 | $-0.37 | · | $-0.31 | $-0.28 | $-0.27 | · | $-0.25 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-139M | $-129M | · | $-116M | $-110M | $-102M | · | $-83M | $-75M | $-64M | · | $-49M | $-43M | $-40M | · | $-39M | |
| Market Cap | $1.27B | $1.12B | · | $617M | $394M | $478M | · | $724M | $557M | $688M | · | $512M | $365M | $222M | · | $177M | |
| Enterprise Value | $1.12B | $946M | · | $522M | $277M | $335M | · | $531M | $462M | $571M | · | $370M | $286M | $134M | · | $69M | |
| P/E | -10.6 | -9.8 | · | -6.6 | -4.5 | -5.7 | · | -9.9 | -9.6 | -13.5 | · | -12.2 | -11.4 | -7.2 | · | -6.2 | |
| P/B | 8.8 | 6.4 | · | 6.5 | 3.3 | 3.2 | · | 3.6 | 5.5 | 5.6 | · | 3.5 | 4.2 | 2.3 | · | 1.5 | |
| P / Tangible Book | 8.8 | 6.4 | · | 6.5 | 3.3 | 3.2 | · | 3.6 | 5.5 | 5.6 | · | 3.5 | 4.2 | 2.3 | · | 1.5 | |
| P / Cash Flow | · | -33.9 | · | · | · | -17.6 | · | · | · | -33.3 | · | · | · | -18.5 | · | · | |
| Earnings Yield | -9.4% | -10.3% | · | -15.1% | -22.4% | -17.7% | · | -10.1% | -10.4% | -7.4% | · | -8.2% | -8.8% | -13.9% | · | -16.1% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-119M | $-96M | $-55M | $-38M | $-43M |
| Diluted EPS | $-0.53 | $-0.48 | $-0.33 | $-0.25 | $-0.32 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.1 | · | 0.2 | 0.2 | 0.2 |
| Current Ratio | 11.8 | · | 15.7 | 22.0 | 11.3 |
| Quick Ratio | 11.6 | · | 15.3 | 21.5 | 11.0 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-101M | · | $-51M | $-35M | $-40M |
Institutional owners (13F) 194 filers · $1.4B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
194
Value held
$1.4B
New positions
23
Exited positions
25
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 23 (-39 vs prior Q) | 25 (+6 vs prior Q) | 72 (+5 vs prior Q) | 58 (+21 vs prior Q) | +4.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| NEA Management Company, LLC | $150,742,986 | 24,471,264 | 10.78% | Shares |
| Bain Capital Life Sciences Investors, LLC | $108,419,826 | 17,600,621 | 7.75% | Shares |
| Venrock Adviser, LLC | $90,835,009 | 14,745,943 | 6.50% | Shares |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $83,585,040 | 13,569,000 | 5.98% | Shares |
| BlackRock, Inc. | $76,966,107 | 12,494,498 | 5.50% | Shares |
| TCG Crossover Management, LLC | $76,151,183 | 12,362,205 | 5.45% | Shares |
| VANGUARD GROUP INC | $60,551,132 | 10,041,647 | 4.33% | Shares |
| Frazier Life Sciences Management, L.P. | $59,880,448 | 9,720,852 | 4.28% | Shares |
| Polar Capital Holdings Plc | $58,777,402 | 9,541,786 | 4.20% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $48,864,477 | 7,932,545 | 3.49% | Shares |
| Nantahala Capital Management, LLC | $42,977,150 | 6,976,810 | 3.07% | Shares |
| STATE STREET CORP | $40,368,624 | 6,553,348 | 2.89% | Shares |
| MARSHALL WACE, LLP | $38,543,053 | 6,256,989 | 2.76% | Shares |
| RTW INVESTMENTS, LP | $36,666,661 | 5,952,380 | 2.62% | Shares |
| Woodline Partners LP | $26,149,933 | 4,245,119 | 1.87% | Shares |
| ORBIMED ADVISORS LLC | $24,392,984 | 3,959,900 | 1.74% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $23,857,705 | 3,872,133 | 1.71% | Shares |
| Spruce Street Capital LP | $21,267,868 | 3,452,576 | 1.52% | Shares |
| Rosalind Advisors, Inc. | $19,577,225 | 3,178,121 | 1.40% | Shares |
| EMERALD ADVISERS, LLC | $19,394,384 | 3,148,439 | 1.39% | Shares |
| Pictet Asset Management Holding SA | $17,020,419 | 2,763,055 | 1.22% | Shares |
| Vestal Point Capital, LP | $16,755,200 | 2,720,000 | 1.20% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $16,600,042 | 2,694,812 | 1.19% | Shares |
| D. E. Shaw & Co., Inc. | $15,492,388 | 2,514,998 | 1.11% | Shares |
| Affinity Asset Advisors, LLC | $15,474,862 | 2,512,153 | 1.11% | Shares |
| EMERALD MUTUAL FUND ADVISERS TRUST | $14,636,154 | 2,375,999 | 1.05% | Shares |
| NAN FUNG TRINITY (HK) LTD | $11,348,876 | 1,842,350 | 0.81% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10,076,762 | 1,635,838 | 0.72% | Shares |
| ADAR1 Capital Management, LLC | $8,644,999 | 1,403,409 | 0.62% | Shares |
| SILVERARC CAPITAL MANAGEMENT, LLC | $8,349,627 | 1,355,459 | 0.60% | Shares |
| ALGERT GLOBAL LLC | $8,188,235 | 1,329,259 | 0.59% | Shares |
| NORTHERN TRUST CORP | $8,025,894 | 1,302,905 | 0.57% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7,211,802 | 1,170,747 | 0.52% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $6,412,597 | 1,041,006 | 0.46% | Shares |
| Longaeva Partners L.P. | $6,257,864 | 1,015,887 | 0.45% | Shares |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $6,219,696 | 1,009,691 | 0.44% | Shares |
| SUPERSTRING CAPITAL MANAGEMENT LP | $6,021,154 | 977,460 | 0.43% | Shares |
| DEUTSCHE BANK AG\ | $5,328,129 | 864,956 | 0.38% | Shares |
| GOLDMAN SACHS GROUP INC | $5,108,767 | 829,345 | 0.37% | Shares |
| SPHERA FUNDS MANAGEMENT LTD. | $4,657,970 | 756,164 | 0.33% | Shares |
| Swedbank AB | $4,409,944 | 715,900 | 0.32% | Shares |
| VOYA INVESTMENT MANAGEMENT LLC | $4,264,020 | 692,211 | 0.30% | Shares |
| F/m Investments LLC | $4,055,461 | 658,354 | 0.29% | Shares |
| Sio Capital Management, LLC | $3,804,878 | 617,675 | 0.27% | Shares |
| AXA Investment Managers S.A. | $3,760,142 | 1,053,261 | 0.27% | Shares |
| KVP Capital Advisors, LP | $3,728,525 | 605,280 | 0.27% | Shares |
| Integral Health Asset Management, LLC | $3,696,000 | 600,000 | 0.26% | Shares |
| BANK OF AMERICA CORP /DE/ | $3,205,393 | 520,356 | 0.23% | Shares |
| UBS Group AG | $3,160,240 | 513,026 | 0.23% | Shares |
| Moody Aldrich Partners LLC | $2,974,005 | 482,793 | 0.21% | Shares |
Activists & 5%+ owners 7 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Growth Equity Opportunities 17, LLC, New Enterprise Associates 17, L.P., NEA Partners 17, L.P., NEA 17 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×4 filings | Nov. 14, 2025 | 12.00% | Amendment | Passive investment | SEC |
| Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP ×5 filings | March 27, 2025 | 9.99% | Amendment | · | SEC |
| High River Limited Partnership, Hopper Investments LLC, Barberry Corp., Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., Carl C. Icahn | Dec. 30, 2015 | · | Initial filing | · | SEC |
| Evan M. Levine, Mark Capital, LLC | Feb. 6, 2009 | · | Initial filing | · | SEC |
| Evan Levine, Mark Capital, LLC ×2 filings | Dec. 19, 2007 | · | Initial filing | · | SEC |
| Matthew Balk ×2 filings | June 1, 2006 | · | Initial filing | Passive investment | SEC |
| High River Limited Partnership S.S. OR, Hopper Investments LLC S.S. OR, Barberry Corp. S.S. OR, Icahn Partners Master Fund LP S.S. OR, Icahn Offshore LP S.S. OR, CCI Offshore Corp. S.S. OR, Icahn Partners LP S.S. OR, Icahn Onshore LP S.S. OR, CCI Onshore Corp. S.S. OR, Carl C. Icahn S.S. OR | Aug. 5, 2005 | · | Initial filing | Board campaign | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 59 insiders · 31 officers · 25 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Matthew Pauls | CHIEF EXECUTIVE OFFICER | Dec. 16, 2025 G | 1,188,050 | 0 | 0 | $0 |
| Robert N Neville | Chief Executive Officer | Dec. 20, 2019 A | 498,028 | 0 | 0 | $0 |
| Brian M Culley | CEO and Director | Jan. 20, 2017 A | 34,500 | 0 | 0 | $0 |
| Evan Levine | CEO & President | Feb. 8, 2008 P | 4,395,000 | 0 | 0 | $0 |
| Nicholas J Virca | CEO and President | Dec. 15, 2003 X | 347,956 | 0 | 0 | $0 |
| David L Lowrance | Chief Financial Officer | June 22, 2026 M | 536,032 | 0 | 1 | $-2,240,919 |
| Brandi Roberts | Chief Financial Officer & SVP | Jan. 20, 2017 A | 38,000 | 0 | 0 | $0 |
| Mark Bagnall | CFO & Executive Vice President | April 3, 2008 A | · | 0 | 0 | $0 |
| Gregory P Hanson | Senior VP, CFO & Treasurer | Dec. 20, 2006 A | · | 0 | 0 | $0 |
| Carrie Carlander | CFO, Treas, Secy, VP Finance | Jan. 31, 2006 A | 25,000 | 0 | 0 | $0 |
| Jaakko Taneli Jouhikainen | President and Chief Operating Officer | Dec. 20, 2019 A | 167,569 | 0 | 0 | $0 |
| Patrick L Keran | President & COO | Jan. 2, 2015 A | · | 0 | 0 | $0 |
| James A Merritt | President & Chf Med Officer | Dec. 14, 2007 P | 35,000 | 0 | 0 | $0 |
| Braden C. Parker | Chief Commercial Officer | Sept. 24, 2026 F | 75,677 | 0 | 0 | $0 |
| Robert Matthew Lutz | Chief Fin. & Operating Officer | July 15, 2026 A | 328,977 | 0 | 0 | $0 |
| Kathleen R. Mccabe | Chief Legal Officer | Dec. 14, 2025 F | 519,232 | 0 | 0 | $0 |
| Anne Erickson | Chief Business Officer | Dec. 14, 2025 F | 371,712 | 0 | 0 | $0 |
| Yasmine Wasfi | Chief Medical Officer | Dec. 4, 2025 F | 168,008 | 0 | 0 | $0 |
| Raymond Dennis Pratt | Chief Medical Officer | Dec. 12, 2024 A | 340,050 | 0 | 0 | $0 |
| Badrul A. Chowdhury | CHIEF MEDICAL OFFICER | Dec. 14, 2021 A | 300,000 | 0 | 0 | $0 |
| Shana Hood | General Counsel & VP | Jan. 20, 2017 A | · | 0 | 0 | $0 |
| Edwin L. Parsley | Chief Medical Officer & SVP | Jan. 20, 2017 A | · | 0 | 0 | $0 |
| Gregory D. Gorgas | Senior VP, Commercial | Jan. 4, 2016 A | · | 0 | 0 | $0 |
| Robert Martin Emanuele | Senior VP, Development | Jan. 4, 2016 A | 294,598 | 0 | 0 | $0 |
| Santosh Vetticaden | Chief Medical Officer & SVP | June 19, 2014 A | · | 0 | 0 | $0 |
| Mark E. Erwin | SVP, Operations | Jan. 30, 2009 A | · | 0 | 0 | $0 |
| Michele Yelmene | VP, Regulatory & QA | Jan. 30, 2009 A | · | 0 | 0 | $0 |
| Joan M Robbins | CSO, Sr. VP | May 14, 2008 P | 10,000 | 0 | 0 | $0 |
| Joachim Ph Schupp | VP, Medical Affairs | March 31, 2008 A | · | 0 | 0 | $0 |
| Mark Joseph Cantwell | VP, Research & Development | Jan. 12, 2007 A | · | 0 | 0 | $0 |
| Cellia Habita | Senior VP, Clinical & Medical | Oct. 7, 2004 P | 5,000 | 0 | 0 | $0 |
| Joseph S Mccracken | Director | Feb. 16, 2026 M | 302,644 | 0 | 0 | $0 |
| David A Ramsay | Director | Dec. 19, 2025 S | 2,533,642 | 0 | 1 | $-121,200 |
| An Van Es-Johansson | Director | Dec. 9, 2025 A | 102,500 | 0 | 0 | $0 |
| Nevan C Elam | Director | Dec. 9, 2025 A | 106,887 | 0 | 0 | $0 |
| Richard J Hawkins | Director | Dec. 9, 2025 A | 161,326 | 0 | 0 | $0 |
| Ricky Sun | Director | Dec. 14, 2023 A | 22,500 | 0 | 0 | $0 |
| Yuri Pikover | Director | Dec. 13, 2018 A | 153,734 | 0 | 0 | $0 |
| Peter Greenleaf | Director | Jan. 20, 2017 A | · | 0 | 0 | $0 |
| DITTRICH HOWARD | Director | Jan. 20, 2017 A | · | 0 | 0 | $0 |
| Lewis Shuster | Director | June 11, 2015 A | · | 0 | 0 | $0 |
| Jack Lief | Director | June 11, 2015 A | · | 0 | 0 | $0 |
| Ted W Love | Director | June 19, 2013 A | · | 0 | 0 | $0 |
| Odysseas D Kostas | Director | June 30, 2010 A | · | 0 | 0 | $0 |
| Eric K Rowinsky | Director | June 30, 2010 A | · | 0 | 0 | $0 |
| Mark Jerome Pykett | Director | June 30, 2010 A | 8,000 | 0 | 0 | $0 |
| Michael M Goldberg | Director | June 30, 2010 A | 26,000 | 0 | 0 | $0 |
| DENNER ALEXANDER J | Director | June 30, 2008 A | · | 0 | 0 | $0 |
| Ross M Johnson | Director | Dec. 21, 2006 X | 1,621,779 | 0 | 0 | $0 |
| Meister, Keith A. | Director | June 2, 2006 A | · | 0 | 0 | $0 |
| Rick Yang | 10% owner | July 17, 2023 P | 24,471,264 | 0 | 0 | $0 |
| Carmen Chang | 10% owner | July 17, 2023 P | 24,471,264 | 0 | 0 | $0 |
| Mohamad Makhzoumi | 10% owner | July 17, 2023 P | 24,471,264 | 0 | 0 | $0 |
| Ali Behbahani | 10% owner | July 17, 2023 P | 24,471,264 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | 10% owner | July 17, 2023 P | 24,471,264 | 0 | 0 | $0 |
| Paul Walker | 10% owner | July 17, 2023 P | 24,471,264 | 0 | 0 | $0 |
| Edward T. Mathers | 10% owner | July 17, 2023 P | 24,471,264 | 0 | 0 | $0 |
| Forest Baskett | 10% owner | July 17, 2023 P | 24,471,264 | 0 | 0 | $0 |
| Scott D. Sandell | 10% owner | July 17, 2023 P | 24,471,264 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 27 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.70% | 59,090 NS | July 31, 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0.62% | 409,369 NS | July 31, 2026 | N-PORT |
| IWC · iShares Trust | 0.19% | 520,275 SH | Sept. 11, 2026 | Daily |
| LABU · Direxion Shares ETF Trust | 0.12% | 108,602 NS | July 31, 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.09% | 301,950 SH | Aug. 19, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.07% | 14,661 SH | Oct. 2, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.06% | 163,980 SH | Aug. 19, 2026 | Daily |
| IWO · iShares Trust | 0.05% | 1,436,801 SH | Sept. 11, 2026 | Daily |
| IBB · iShares Trust | 0.04% | 822,223 SH | Sept. 11, 2026 | Daily |
| PWS · Pacer Funds Trust | 0.03% | 1,484 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 880,662 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.03% | 73,241 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.03% | 3,929,899 SH | Sept. 11, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 103,677 SH | Oct. 2, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 1,567,813 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.01% | 277,850 SH | Aug. 19, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 43,814 NS | July 31, 2026 | N-PORT |
| ISCG · iShares Trust | 0.01% | 12,952 SH | Sept. 10, 2026 | Daily |
| TILT · FlexShares Trust | 0.00% | 19,118 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.00% | 5,664 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 43,112 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.00% | 170,809 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 23,796 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 6,164,961 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 11,396 SH | Aug. 19, 2026 | Daily |
| ISCB · iShares Trust | · | 4,332 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 11,041 SH | Sept. 11, 2026 | Daily |
SVRA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 14 analysts
BUY
Median target
$10.25
+113.1%
5 35.7%
Strong Buy
8 57.1%
Buy
1 7.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
8 analysts · 2026-09-28Mean target $10.94 +127.4%
← Below all targets
Current price $4.81
Low$9.00
Mean$10.94
High$16.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| SVRA | $1.23B | -11.4 | · | · | -73.4% | · |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | · |
| AKTS | · | · | · | · | · | · |
| CGEM | $624M | -3.2 | · | · | -44.0% | · |
| ODTX | · | · | · | · | · | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 11, 2026